Day 1 : Workshop
| |||
---|---|---|---|
TIME (GMT+7) | Workshop 1 | Workshop 2 | Workshop 3 |
08.00-14.30 |
Targeted Hypertension Care : Tailoring Treatment Across Multiple Conditions
Chair: Tities Anggraeni Indra, MD |
Challenges in hypertension : How to session
Chair: Cep Juli, MD |
Workshop of Hypertension By Omron Academy
Chair: Rarsari Soerarso Pratikto, MD |
08:00 - 08:30 | Registration | Registration | Registration |
08:30 - 08:40 | Pre Test | Pre Test | Pre Test |
08:40 - 09:00 | Hypertension in High Risk Occupation Made Junior Rina Artha |
How to optimize hypertension outcomes with home blood pressure monitoring Triwedia Indradewi |
|
09:00 - 09:30 | Hypertension and Sport : Balancing Fitness and Safety Ade Median Ambari |
How to identify and diagnose secondary hypertension in young adults Widodo |
How to Assess Blood Pressure Variability Rarsari Soerarso Pratikto |
09:30 - 10:00 | Comprehensive Strategies in Managing Obesity Related Hypertension Yulia Sofiatin |
Hypertension - Induced Cerebral Small Vessel Disease: How to Manage? Paulus Anam Ong |
The Impact of Morning Blood Pressure Surge in Cerebrovascular Disease Eka Harmeiwaty |
10:00 - 10:15 | Coffee Break | Coffee Break | Coffee Break |
10:15 - 10:45 | Managing Hypertension in the Elderly : Promoting Healthy Aging Abdul Wahid |
How to manage masked hypertension : a comprehensive approach Chandra Irwanadi Mohani |
Home Blood Pressure Variability: Risk Prediction for Cardiovascular Disease Badai Tiksnadi |
10:45 - 11:15 | Treatment of Hypertension in Coronary Artery Disease A. Sari S. Mumpuni |
Hypertension mediated organ damage : how to assess and intervene Marihot Tambunan |
How to Manage Blood Pressure in Chronic Kidney Disease Nyoman Paramita Ayu |
11:15 - 11:30 | Q&A | Q&A | Q&A |
11:30 - 13:00 | Friday Praying & Lunch | Friday Praying & Lunch | Friday Praying & Lunch |
13:00 - 13:30 | Interactive Case Discussion Dimas Septiar |
Interactive case discussion Oryza Gryagus |
Hands on by OMRON |
13:30 - 14:30 | Interactive case discussion : Management of Hypertension in Multiple Organ Damage Eka Harmeiwaty |
||
14:30 - 14:40 |
Day 2 : Symposium
| |||
---|---|---|---|
TIME (GMT+7) | Ballroom 1 | Ballroom 2 | Ballroom 3 |
07.50-08.00 | Ethical Issues in Managing Hypertension Pukovisa Prawiroharjo |
||
08.00-08.40 | Morning Talks On Hypertension Zulkhair Ali |
||
08.00 - 08.10 | Resistant Hypertension: A Practical Clinical Approach for Diagnosis and Treatment
Interactive Case Study 1: Resistant Hypertension Case Presenter: Anandhara Indriani K Panelists: Sari Mumpuni, Chandra Irawadi M, Yuda Turana |
||
08.30 - 08.40 | Discussion | ||
08.40-09.30 | Plenary Session Wiguno Prodjosudjadi |
||
08.40 - 09.05 | How to manage hypertension in 2025: International consensus? George Stergiou (International Society of Hypertension) |
||
09.05 - 09.30 | Primordial Hypertension: shaping national health strategies for prevention and management Teguh Ranakusuma |
||
09.30-10.00 | Opening Ceremony | ||
10.00-10.30 | Coffee Break | ||
10.30-11.30 |
Symposium 1 Consequences of Hypertension to the Brain, Heart and Kidney: Strategies to Improve Outcomes Chair: Lisda Amalia, MD |
Symposium 2 Hypertension and Dyslipidemia as a Double Burden of Cerebro Vascular Disease Chair: Jose Roesma, MD |
Symposium 3 Navigating the Complex Relationship: Heart Failure and Cardiorenal Syndrome Chair: Erwinanto, MD |
10:30 - 10:45 | (OC) Stroke Prevention in Heart Failure Patients Rahmat Hidayat |
(OC) Genetic Analyses of Lipid Risk Factors for Atherosclerosis Bambang Purwanto |
(OC) Updates on Cardiorenal Continuum Ria Bandiara |
10:45 - 11:00 | Tackling HFrEF: Tactics for superior long-term outcomes Rossana Barack |
Updated Pharmacological Approaches to Hypertension Management Yenny Kandarini |
Unlocking Hope Across Heart Failure's Ejection Fractions: Dapagliflozin's Position on Latest Guideline Therapy Badai Tiksnadi |
11:00 - 11:15 | ARNI in patients with HFrEF and renal impairment: where do we stand? Sally A. Nasution |
Comprehensive Treatment of Stroke related to Hypertension and Dyslipidemia Mursyid Bustami |
Advancements in Hyperkalemia Management for Cardiorenal Syndrome: New Therapeutic Strategies Ginnova Nainggolan |
11:15 - 11:30 | Discussion | Discussion | Discussion |
11.30-12.30 |
Lunch Symposium 1 JOINT SESSION InaSH - ISH and HOPE ASIA NETWORK Chair: Anwar Santoso, MD |
Lunch Symposium 2 Mastering Hypertension: Innovations and Strategies for Optimal Blood Pressure Control Chair: Yuda Turana, MD |
Lunch Symposium 3 Pioneering Cerebrocardiorenal Complications in Hypertension Chair: Ekawatidani Yulianti, MD |
11:30 - 11:45 | Current issues and future perspectives in blood pressure measurement and hypertension diagnosis George Stergiou (International Society of Hypertension) |
Integrative Strategies from the ESH 2024 MASTERplan Claudio Borghi (European Society of Hypertension) |
Guardian of the heart - our superpower in managing all spectrum HF Siska Suridanda Dany |
11:45 - 11:50 | Protector of the kidney - easing our CKD patients Pranawa Martosuwignyo |
||
11:50 - 12:00 | Use of angiotensin-receptor neprilysin inhibitor for the management of hypertension Jiguang Wang (HOPE Asia Network) |
Multiple Power on Blood Pressure Control to Prevent Cardio-Renal Complications Djoko Wibisono |
|
12:00 - 12:10 | Tackling the scourge of CVD and CKD with the duo force Yan Herry |
||
12:10 - 12:15 | Discussion | Discussion | |
12:15 - 12:30 | Discussion | ||
12.30-13.30 | Lunch | ||
13.30-14.30 |
Symposium 4 ACE Inhibitor and Beta Blocker in the Management of Hypertension Chair: Ni Made Hustrini, MD |
Symposium 5 Exploring Gut Hypertension Axis: Integrating Single Pill Combinations For Optimized CV Management Chair: Nyoman Paramita Ayu, MD |
Symposium 6 Burden of Hypertension to Brain, Heart and Kidney Chair: Santoso Karo Karo, MD , Co-Chair: Dinda Diafiri, MD |
13:30 - 13:45 | (OC) Interaction Between the Symphatetic Nervous System and Renin Angiotensin Aldosterone in Hypertension Zulkhair Ali |
(OC) Exploring New Therapeutic Options of Microbiota - Derived Metabolites in Blood Pressure Regulation Afiatin |
(OC) New Insight into Cerebrovascular Pathophysiology in Hypertension Cep Juli |
13:45 - 14:00 | Upstream and Downstream Pathway Intervention in controlling Hypertension and Preventing the complication: The Power of ACE-i Saifur Rohman |
Understanding the Link Between TMAO and Cardiovascular Disease: From Pathophysiology to Therapeutic Strategies Bambang Widyantoro |
Optimizing Telmisartan in Managing Hypertension: Beyond Blood Pressure Lowering Effect Pringgodigdo Nugroho |
14:00 - 14:15 | The Role of Vasodilator Beta Blocker as Anti Hypertensive Agents in Specific Population (Nebivolol) Paskariatne Probodewi |
Improving Hypertension Treatment and Control: the challenge and how to overcome it with Single Pill Combination Haerani Rasyid |
How to Improve Management of Hypertension Related Proteinuria Tunggul D. Situmorang |
14:15 - 14:30 | Discussion | Discussion | Discussion |
14.30-15.30 |
Symposium 7 The Innovations in Hypertension Monitoring Chair: Tunggul D. Situmorang, MD |
Symposium 8 Evidence to Practice: Renal Denervation as a treatment for Hypertension Chair: Amanda Tiksnadi, MD |
Symposium 9 Management of ASCVD and Type 2 Diabetes Chair: Yulia Sofiatin, MD |
14:30 - 14:45 | Machine Learning Models for Early Detection and Diagnosis in Hypertension I Made Putra Swi Antara |
(OC) Recent Update on Resistant Hypertension Bagus Andi Pramono |
(OC) Managing Hypertension in Diabetes: Strategies for Integreted Care and Optimal Outcomes Rudi Supriyadi |
14:45 - 15:00 | Cuffless Blood Pressure Monitoring Device for Better Hypertension Control Hae Young Lee (Korean Society of Hypertension) |
The Evidence : The Spyral HTN Clinical program Faris Basalamah |
Managing People with ASCVD and Type 2 Diabetes: What Do Recent Guidelines Say Antonia Anna Lukito |
15:00 - 15:15 | The Early Echocardiographic Signs in Hypertensive Heart Disease BRM Ario Soeryo |
Selecting the right patients for Renal Denervation Maruhum Bonar Marbun |
GLP-1 RA Semaglutide Once-Weekly: A Novel Treatment Choice for People with ASCVD and T2D Dicky Tahapary |
15:15 - 15:30 | Discussion | Discussion | Discussion |
15.30-15.45 | Wrap Up | ||
15.45-16.00 | Doorprize |
TIME (GMT+7) | Ballroom 1 | Ballroom 2 | Ballroom 3 |
08.00-09.00 | Plenary Session 2 Pringgodigdo Nugroho |
||
08.00 - 08.30 | ENVIRONMENTAL CHALLENGES IN MANAGING HYPERTENSION IN INDONESIA: PERSPECTIVE FROM THE POLICY MAKER Siti Nadia Tarmizi (Ministry of Health, P2PTM) |
||
08.30 - 09.00 | PERSPECTIVE OF HYPERTENSION MANAGEMENT IN ASIA Jiguang Wang (HOPE Asia Network) |
||
09.00-09.30 | INASH Award | ||
09.30-10.30 |
Symposium 10 Hypertension In The Early Age and Pregnancy Chair: Frits R.W. Suling, MD |
Symposium 11 Joint Session InaSH APSH KSH: Obesity, Metabolic Syndrome and Hypertension Chair: Arieska Ann Soenarta, MD , Co-Chair: Anandhara Indriani K, MD |
Symposium 12 Hypertension In Central and Peripheral Vascular Disease Chair: Afiatin, MD |
09:30 - 09:45 | Hypertension in Pediatric Populations: Causes, Consequences and Prevention Strategies Dany Hilmanto |
Improving Hypertension control using impedance cardiography Teo Boon Wee (Asia Pacific Society of Hypertension) |
The Effects of Hypertension on Cerebral Autoregulation and Brain Health Ekawatidani Yulianti |
09:45 - 10:00 | Hypertension in Adolescent Populations: Strategies for Effective Management Radityo Prakoso |
Long term impact of new-onset diabetes mellitus in hypertensive patients Hae Young Lee (Korean Society of Hypertension) |
Managing Hypertension to Mitigate Dementia Risk and Treatment Strategies Syahrul Gazali |
10:00 - 10:15 | Management of hypertension in pregnancy : optimizing maternal and fetal outcomes Alamsyah |
Obesity and Hypertension: Where do Indonesia stand? Anwar Santoso |
Hypertension and Peripheral Arterial Disease Hananto Andriantoro |
10:15 - 10:30 | Discussion | Discussion | Discussion |
10.30-11.00 | Coffee Break | ||
11.00-12.00 |
Symposium 13 Secondary Prevention on ASCVD Chair: Yenny Kandarini, MD |
Symposium 14 State of the Art Anti Hypertensive Combination Chair: Rossana Barack, MD |
Symposium 15 CCB: Beyond Blood Pressure Lowering Effect to Atherogenesis Chair: Eka Musridharta, MD |
11:00 - 11:15 | (OC) Lipid-Lowering Combination Therapy: What The Guidelines Say? Bambang Budi Siswanto |
Rationale of Anti Hypertensive Combination Eka Harmeiwaty |
Vascular Calcium Channel and High Blood Pressure Erwinanto |
11:15 - 11:30 | Intensifying Lipid Management in Stroke Therapy: Current Strategies and Future Directions Valentinus Besin |
How Can We Do Better in Hypertension Management with Fixed Dose Combination Syafrizal Nasution |
The Evolution of CCB as Anti Hypertensive Agent Aryatama |
11:30 - 11:45 | The Role of Lipid-Lowering Combination Therapy in Managing Complex Cardiovascular Conditions Adrianus Kosasih |
Targeting Cardiovascular Risk in Hypertension : A Pathway to Better Outcomes Celly Anantaria |
The role of amlodipine in blood pressure control triage: Achieving cardiovascular protection Ria Bandiara |
11:45 - 12:00 | Discussion | Discussion | Discussion |
12.00-13.00 | Lunch | ||
13.00-14.00 |
Lunch Symposium 4 ESC 2024 Hypertension Guidelines Chair: Antonia Anna Lukito, MD |
Lunch Symposium 5 Hypertension In Elderly Chair: Suhardjono, MD , Co-Chair: Tities Anggraeni Indra, MD |
Lunch Symposium 6 Hypertension and Chronic Kidney Disease Chair: Adre Mayza, MD |
13:00 - 13:20 | What's New on ESC 2024 Guidelines: Introducing Elevated Blood Pressure Estu Rudiktyo |
Hypertension in eldelry : how to to diagnose Artaria Tjempakasari |
The Effects of Hypertension on Renal Blood Flow Ni Made Hustrini |
13:20 - 13:40 | Pathophysiology and Clinical Consequeces of Elevated Blood Pressure Lestariningsih |
Updates on Guidelines for the Management of Hypertension in Older People Yuda Turana |
Managing Hypertension in Kidney Transplant Recipient Endang Susalit |
13:40 - 14:00 | Discussion | Discussion | Discussion |
14.00-14.30 | Wrap Up | ||
14.30-15.00 | LAUNCHING InaSH PRACTICAL GUIDE BOOK | ||
15.00-15.30 | CLOSING REMARK AND DOOR PRIZE |